Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Ixodes ricinus salivary gland proteome during feeding and B. Afzelii infection: New avenues for an anti-tick vaccine

MJ. Klouwens, JJA. Trentelman, D. Barriales, JI. Ersoz, M. Azkargorta, F. Elortza, R. Šíma, O. Hajdušek, JL. Lavin, J. Tomás Cortazar, I. Escobes Corcuera, E. Colstrup, A. Nayak, I. Martín Ruíz, H. Rodriguez, AM. Nijhof, J. Anguita, JWR. Hovius

. 2023 ; 41 (12) : 1951-1960. [pub] 20230214

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003783
E-zdroje Online Plný text

NLK ProQuest Central od 2002-01-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health & Medicine (ProQuest) od 2002-01-01 do Před 2 měsíci
Family Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health Management Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Public Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci

Odkazy

PubMed 36797101
DOI 10.1016/j.vaccine.2023.02.003
Knihovny.cz E-zdroje

INTRODUCTION: Borrelia burgdorferi sensu lato, the causative agents of Lyme borreliosis, are transmitted by Ixodes ticks. Tick saliva proteins are instrumental for survival of both the vector and spirochete and have been investigated as targets for vaccine targeting the vector. In Europe, the main vector for Lyme borreliosis is Ixodes ricinus, which predominantly transmits Borrelia afzelii. We here investigated the differential production of I. ricinus tick saliva proteins in response to feeding and B. afzelii infection. METHOD: Label-free Quantitative Proteomics and Progenesis QI software was used to identify, compare, and select tick salivary gland proteins differentially produced during tick feeding and in response to B. afzelii infection. Tick saliva proteins were selected for validation, recombinantly expressed and used in both mouse and guinea pig vaccination and tick-challenge studies. RESULTS: We identified 870 I. ricinus proteins from which 68 were overrepresented upon 24-hours of feeding and B. afzelii infection. Selected tick proteins were successfully validated by confirming their expression at the RNA and native protein level in independent tick pools. When used in a recombinant vaccine formulation, these tick proteins significantly reduced the post-engorgement weights of I. ricinus nymphs in two experimental animal models. Despite the reduced ability of ticks to feed on vaccinated animals, we observed efficient transmission of B. afzelii to the murine host. CONCLUSION: Using quantitative proteomics, we identified differential protein production in I. ricinus salivary glands in response to B. afzelii infection and different feeding conditions. These results provide novel insights into the process of I. ricinus feeding and B. afzelii transmission and revealed novel candidates for an anti-tick vaccine.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003783
003      
CZ-PrNML
005      
20230425140901.0
007      
ta
008      
230418s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.vaccine.2023.02.003 $2 doi
035    __
$a (PubMed)36797101
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Klouwens, Michelle J $u Department of Internal Medicine, Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Division of Infectious Diseases, Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands; Amsterdam Multidisciplinary Lyme borreliosis Center, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: m.j.klouwens@amsterdamumc.nl
245    14
$a The Ixodes ricinus salivary gland proteome during feeding and B. Afzelii infection: New avenues for an anti-tick vaccine / $c MJ. Klouwens, JJA. Trentelman, D. Barriales, JI. Ersoz, M. Azkargorta, F. Elortza, R. Šíma, O. Hajdušek, JL. Lavin, J. Tomás Cortazar, I. Escobes Corcuera, E. Colstrup, A. Nayak, I. Martín Ruíz, H. Rodriguez, AM. Nijhof, J. Anguita, JWR. Hovius
520    9_
$a INTRODUCTION: Borrelia burgdorferi sensu lato, the causative agents of Lyme borreliosis, are transmitted by Ixodes ticks. Tick saliva proteins are instrumental for survival of both the vector and spirochete and have been investigated as targets for vaccine targeting the vector. In Europe, the main vector for Lyme borreliosis is Ixodes ricinus, which predominantly transmits Borrelia afzelii. We here investigated the differential production of I. ricinus tick saliva proteins in response to feeding and B. afzelii infection. METHOD: Label-free Quantitative Proteomics and Progenesis QI software was used to identify, compare, and select tick salivary gland proteins differentially produced during tick feeding and in response to B. afzelii infection. Tick saliva proteins were selected for validation, recombinantly expressed and used in both mouse and guinea pig vaccination and tick-challenge studies. RESULTS: We identified 870 I. ricinus proteins from which 68 were overrepresented upon 24-hours of feeding and B. afzelii infection. Selected tick proteins were successfully validated by confirming their expression at the RNA and native protein level in independent tick pools. When used in a recombinant vaccine formulation, these tick proteins significantly reduced the post-engorgement weights of I. ricinus nymphs in two experimental animal models. Despite the reduced ability of ticks to feed on vaccinated animals, we observed efficient transmission of B. afzelii to the murine host. CONCLUSION: Using quantitative proteomics, we identified differential protein production in I. ricinus salivary glands in response to B. afzelii infection and different feeding conditions. These results provide novel insights into the process of I. ricinus feeding and B. afzelii transmission and revealed novel candidates for an anti-tick vaccine.
650    _2
$a zvířata $7 D000818
650    _2
$a morčata $7 D006168
650    _2
$a myši $7 D051379
650    12
$a klíště $7 D018884
650    _2
$a proteom $7 D020543
650    _2
$a arachnida jako vektory $7 D001096
650    12
$a lymeská nemoc $x prevence a kontrola $7 D008193
650    _2
$a slinné žlázy $7 D012469
650    _2
$a proteiny členovců $7 D060829
650    12
$a vakcíny $7 D014612
655    _2
$a časopisecké články $7 D016428
700    1_
$a Trentelman, Jos J A $u Department of Internal Medicine, Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Barriales, Diego $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain
700    1_
$a Ersoz, Jasmin I $u Department of Internal Medicine, Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Azkargorta, Mikel $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
700    1_
$a Elortza, Felix $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
700    1_
$a Šíma, Radek $u Biology Centre, Institute of Parasitology, Czech Academy of Sciences, Ceske Budejovice, Czech Republic; Biopticka laborator s.r.o., Plzen, Czech Republic
700    1_
$a Hajdušek, Ondrej $u Biology Centre, Institute of Parasitology, Czech Academy of Sciences, Ceske Budejovice, Czech Republic
700    1_
$a Lavin, José-Luis $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain
700    1_
$a Tomás Cortazar, Julen $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain
700    1_
$a Escobes Corcuera, Iraide $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
700    1_
$a Colstrup, Emil $u Department of Internal Medicine, Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Nayak, Abhijeet $u Department of Internal Medicine, Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Martín Ruíz, Itziar $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain
700    1_
$a Rodriguez, Hector $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain
700    1_
$a Nijhof, Ard M $u Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany; Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, Berlin, Germany
700    1_
$a Anguita, Juan $u CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Derio, Spain; Ikerbasque, Basque foundation for science, Bilbao, Spain
700    1_
$a Hovius, Joppe W R $u Department of Internal Medicine, Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Division of Infectious Diseases, Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands; Amsterdam Multidisciplinary Lyme borreliosis Center, Academic Medical Center, Amsterdam, The Netherlands
773    0_
$w MED00004631 $t Vaccine $x 1873-2518 $g Roč. 41, č. 12 (2023), s. 1951-1960
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36797101 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140857 $b ABA008
999    __
$a ok $b bmc $g 1924450 $s 1189992
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 41 $c 12 $d 1951-1960 $e 20230214 $i 1873-2518 $m Vaccine $n Vaccine $x MED00004631
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace